Clinical trial
Apixaban vs. Warfarin in Left Ventricular Thrombus: A Randomized, Noninferiority Trial
NCT07709780 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Apixaban vs. Warfarin in Left Ventricular Thrombus: A Randomized, Noninferiority Trial
- Lead sponsor
- University of Arizona
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- June 22, 2026
- Completion date
- July 1, 2029
- Enrollment
- 218 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
left ventricular thrombus